Anna Richo

Insider Reports History

Entity
Individual
Location
Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA
Signature
David T Skinner, attorney-in-fact for Anna Richo
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anna Richo:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ILLUMINA, INC. Director Common Stock 2.62K $302K $115.01 May 16, 2024 Direct
EXELON CORP Director Common stock- deferred stock units 5.14K $207K $40.23 Sep 30, 2024 By Exelon Corp. Directors Deferred Stock Unit Plan
EXELON CORP Director Deferred phantom share equivalents 3.98K $162K $40.55 Sep 30, 2024 Direct
Adamas Pharmaceuticals Inc Director Common Stock 0 $5.16 Nov 24, 2021 Direct
Adamas Pharmaceuticals Inc Director Stock Option (Right to Buy) 0 Nov 24, 2021 Direct

Insider Reports Filed by Anna Richo

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EXC EXELON CORP Sep 30, 2024 2 $72.5K 4 Oct 2, 2024 Director
EXC EXELON CORP Jun 30, 2024 2 $72.5K 4 Jul 2, 2024 Director
ILMN ILLUMINA, INC. May 16, 2024 1 $0 4 May 22, 2024 Director
ILMN ILLUMINA, INC. May 16, 2024 0 $0 3 May 22, 2024 Director
EXC EXELON CORP Mar 31, 2024 2 $72.5K 4 Apr 2, 2024 Director
EXC EXELON CORP Dec 31, 2023 2 $72.5K 4 Jan 2, 2024 Director
EXC EXELON CORP Sep 30, 2023 2 $47.7K 4 Oct 2, 2023 Director
EXC EXELON CORP Aug 1, 2023 0 $0 3 Aug 2, 2023 Director
ADMS Adamas Pharmaceuticals Inc Nov 24, 2021 3 $0 4 Nov 24, 2021 Director
ADMS Adamas Pharmaceuticals Inc Jun 2, 2021 2 $0 4 Jun 4, 2021 Director